Triatomic Capital is on record against 14 companies.
Early-to-growth investor targeting infrastructure-focused, cross‑vertical applied AI for physical-world and life‑science problems. They bring deep health‑tech and healthcare-systems expertise bridging regulated care and frontier deep‑tech. Geographic focus: US and APAC.